Omo Fadeyi on Muck Rack

Omo Fadeyi

As seen in: The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Omo

Contact Omo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound

|
By Benjamin Varco-Merth, Alejandra Marenco, Were R. Omange, Omo Fadeyi
| The Journal of Clinical Investigation
ResearchAIDS/HIVImmunology Open Access | 10.1172/JCI198294 J Clin Invest. https://doi.org/10.1172/JCI198294. Copyright © 2026, Omange et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract HIV/SIV-specific CD8+ T cell responses are typically unable to control viral rebound following antiretroviral therapy (ART) interruption (ATI).
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified